incorrect again it’s how the phase 1 study was designed. Not one presentation or announcement has indicated that this design was for multiple conditions as each condition needs a different dose timing and concentration.
AGN Media thread, page-128
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
86.5¢ |
Change
0.055(6.79%) |
Mkt cap ! $105.5M | |||
| Open | High | Low | Value | Volume |
| 82.5¢ | 86.5¢ | 81.0¢ | $114.4K | 136.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 18772 | 85.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 86.5¢ | 32000 | 1 |
View Market Depth
| Last trade - 12.42pm 12/08/2024 (20 minute delay) ? |
| AGN (ASX) Chart |